| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063723 One pot synthesis; formylation, oximination, cyanation, saponification and amidation of indole ester |
| 04/01/2004 | US20040063709 Acute and chronic inflammatory disorders; cancer |
| 04/01/2004 | DE10244282A1 Zubereitung mit antioxidanten Eigenschaften Composition having antioxidant properties |
| 03/31/2004 | EP1402253A2 A process for the isolation of a major harmful oxidant from cigarette smoke |
| 03/31/2004 | EP1401862A2 Peptide compounds for counteracting reactive oxygen species and free radicals |
| 03/31/2004 | EP1232174A4 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 03/31/2004 | EP1232144B1 Novel il-8 receptor antagonists |
| 03/31/2004 | EP1210102A4 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 03/31/2004 | EP0977578B1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 03/31/2004 | CN1486177A Method and preparation for binding acetaldehyde in saliva, stomach and large intestine |
| 03/31/2004 | CN1485028A Lycopene drop pill |
| 03/30/2004 | US6713091 With licorice; beverage for curing a hangover, source of dietary fiber |
| 03/30/2004 | US6713074 Cosmetic composition and method |
| 03/30/2004 | CA2339073C Composition for suppressing cellular fibrousing and method for preparing an extract from loquat seeds |
| 03/25/2004 | WO2003075903A3 Use proline and its functional equivalentsfor quenching ros and/ or radicals |
| 03/25/2004 | WO2003043613A3 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 03/25/2004 | US20040059107 Which has superoxide acitivity, catalase activity, and/or peroxidase activity; for treating cell or tissue damage; pharmaceutical formulations, improved cell and organ culture media, cryopreservation media, antiaging, chemoprotective and radioprotective uses |
| 03/25/2004 | US20040058981 Administering free radical generators such as artemisinim, arteflene |
| 03/25/2004 | US20040058925 Method of treating fibromyalgia and other somatoform disorders |
| 03/25/2004 | US20040058022 Method for producing fat and /or solids from beans and compositions containing polyphenols |
| 03/25/2004 | US20040057913 For therapy and prophylaxis of inflammatory due to ultraviolet radiation |
| 03/24/2004 | EP1400579A2 Composition with anti-oxidative properties |
| 03/24/2004 | EP1399439A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 03/24/2004 | EP1399150A1 Vitamin c compositions |
| 03/24/2004 | EP1399147A2 Therapeutic delivery of carbon monoxide |
| 03/24/2004 | EP1399033A1 Method for processing ginseng and processed ginseng obtained by the same |
| 03/24/2004 | EP1303517B1 Indoloquinazolinones |
| 03/24/2004 | EP1033981B1 Formulations and methods for reducing toxicity of antineoplastic agents |
| 03/24/2004 | CN1484644A Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/24/2004 | CN1484537A Pharmacentical preparation for douches and/or irrigations of natural or puthological cavities in human body |
| 03/24/2004 | CN1484528A Pharmaceutical composition comprising wikstromol and/or mataires inal, its use as hepatoprotectant and process for their isolation from cedurs deodara |
| 03/24/2004 | CN1484524A 5-HT IA veceptor subtype agonist |
| 03/24/2004 | CN1483476A Process for preparing antitoxin toxinicide |
| 03/24/2004 | CN1142996C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 03/24/2004 | CN1142928C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/18/2004 | WO2004007475A8 Flavonoid compounds as therapeutic antioxidants |
| 03/18/2004 | WO2003084936A3 Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological |
| 03/18/2004 | US20040054001 For preparing a pharmaceutical composition for treating diseases that may be influenced by NF-kappaB, particularly psoriasis |
| 03/18/2004 | US20040053993 Compositions of tocol-soluble therapeutics |
| 03/18/2004 | US20040053963 Urotensin-II receptor antagonists |
| 03/18/2004 | US20040053957 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization |
| 03/18/2004 | US20040053942 Fused pyrazole derivatives bieng protein kinase inhibitors |
| 03/18/2004 | US20040053842 Cholesterol ester transfer protein inhibitors for use in treating atherosclerosis optionally in combination with other antihypertensive agents |
| 03/18/2004 | US20040052873 Bioavailability / bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 03/18/2004 | US20040052739 Sunscreen agents; radiation resistance |
| 03/17/2004 | EP1398035A1 Topical cutaneous application of emulsions characterised by their antiprostanoidic properties |
| 03/17/2004 | EP1397366A1 Novel ligand for nicotinic acetylcholine receptors useful in therapy |
| 03/17/2004 | EP1397363A1 5-ethyl-imidazotriazinones |
| 03/17/2004 | EP0655917B1 Crystalline amifostine compositions and methods for the preparation and use of same |
| 03/17/2004 | CN1483032A Process for making substituted 8-arylquinolinium benzenesulfonate |
| 03/17/2004 | CN1483021A Novel 1, 2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| 03/17/2004 | CN1482864A Composition and method |
| 03/17/2004 | CN1481793A Ginkgo leaf extract and injection fluid containing same |
| 03/17/2004 | CN1481784A Slow releasing micro-encapsulation compound antioxidant |
| 03/16/2004 | US6706750 Useful in treating obesity and other disorders |
| 03/16/2004 | US6706724 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 03/16/2004 | US6706719 Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 03/11/2004 | WO2004020433A1 Novel crystals |
| 03/11/2004 | WO2004019972A1 Use of erythopoietin |
| 03/11/2004 | WO2004019936A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions |
| 03/11/2004 | WO2003099759A8 Preparation and application of transhintotalphenolic acid |
| 03/11/2004 | WO2003041736A3 Method for the treatment of cardiotoxicity induced by antitumor compounds |
| 03/11/2004 | US20040048875 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 03/11/2004 | US20040047922 Prevents the development of atherosclerosis |
| 03/11/2004 | US20040047834 An agent for promoting excretion of an accumulative chlorine compound comprising a pharmaceutically acceptable anion exchange resin, which is a novel agent that is for promoting the excretion of an accumulative chlorine compound and is |
| 03/11/2004 | US20040047832 Cosmetic and/or dermopharmaceutical preparations containing leaf extracts of the plant argania spinosa |
| 03/11/2004 | US20040047824 Topical use containing at least one oxidation-sensitive hydrophilic active principle and at least one maleic anhydride copolymer, comprising one or more maleic anhydride comonomers and one or more comonomers selected from the group |
| 03/11/2004 | DE10240343A1 Peroxynitrit-Umlagerungskatalysatoren Peroxynitrite rearrangement catalysts |
| 03/11/2004 | CA2496581A1 The use of erythopoieitin in the treatment of disturbances of iron distribution in diabetes |
| 03/11/2004 | CA2495437A1 Novel crystal |
| 03/11/2004 | CA2493199A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions |
| 03/10/2004 | EP1396271A1 Use of germination-activated ganoderma lucidium spores as anti-aging agent and against menopause symptoms |
| 03/10/2004 | EP1395561A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
| 03/10/2004 | CN1481237A Method for producing organic solvent-free lycopene concentrate, resulting concentrate and compsn comprising said concentrate |
| 03/10/2004 | CN1480132A Protective solution for preventing local ischemic damage |
| 03/10/2004 | CN1141107C Nutritive liquor detoxicating with function |
| 03/09/2004 | US6703425 Sulfonamide derivatives |
| 03/09/2004 | US6703408 N-formyl derivatives of paroxetine |
| 03/09/2004 | US6703389 Optically pure reboxetine or its methanesulfonate salt inhibits reuptake of norepinephrine |
| 03/04/2004 | WO2004018434A1 Pyrimidine compounds |
| 03/04/2004 | WO2004018412A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 03/04/2004 | WO2004017966A1 Five-membered heterocyclic compounds in the treatment of chronic and acute pain |
| 03/04/2004 | WO2004017965A1 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain |
| 03/04/2004 | WO2004017959A2 Antioxidant and radical scavenging activity of synthetic analogs of desferrithiocin |
| 03/04/2004 | WO2004017920A2 Novel biphenyl and biphenyl-like cannabinoids |
| 03/04/2004 | WO2003065871A3 Methods and compositions for treating hematological disorders |
| 03/04/2004 | WO2003016348A3 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine |
| 03/04/2004 | WO2003011114A3 Methods for treating prostatitis |
| 03/04/2004 | WO2002022134A8 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals |
| 03/04/2004 | US20040044213 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 03/04/2004 | US20040043002 Polyol-IFN-beta conjugate and composition containing same |
| 03/04/2004 | US20040042990 Composition containing oxidation-sensitive hydrophilic active principle and maleic anhydride copolymer, and use thereof |
| 03/04/2004 | CA2495903A1 Novel biphenyl and biphenyl-like cannabinoids |
| 03/03/2004 | EP1394161A1 L−ASCORBIC ACID−2−O−MALEIC ACID−A−TOCOPHEROL DIESTER 1−PROPANOL ADDUCT AND PROCESS FOR PRODUCING THE SAME |
| 03/03/2004 | EP1392840A2 Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same |
| 03/03/2004 | EP1392661A1 Diarylurea derivatives useful as anti-inflammatory agents |
| 03/03/2004 | EP1392324A1 Chemoprotection using amifostine and related compounds |
| 03/03/2004 | EP1392289A2 Caspase inhibitors and uses thereof |
| 03/03/2004 | EP1392285A1 Medicament containing an effector of the glutathione metabolism together with alpha-lipoic acid for use in kidney replacement therapy |